Ingenia Therapeutics인제니아테라퓨틱스(Reg.S)
950260 · KOSDAQ · ₩950260 · 인제니아테라퓨틱스(Reg.S)
- Market cap
- ₩1.1T
- Enterprise value
- ₩1.1T
- P/E
- —
- P/B
- 116,557.6×
- Dividend yield
- —
- ROE
- —
- Net margin
- —
Trailing 12 months from filed financial statements, as of H1 2026.
52-week range−22.4% from the high
₩9,900Today: ₩23,000 – ₩24,250₩29,950
Returns
- 1W+5.4%
- 1M−4.7%
- 3M—
- 6M—
- YTD+29.2%
- 1Y—
- Volume today
- 278,721
- 0.3× the 20-day average
- Traded today
- ₩6.6B
- Listed shares
- 49,444,607
- EPS (12 months)
- —
🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 33 of 100 (50 is a normal day for this stock).
- MomentumFlat-0.9% over the last month; the price is below its 20-day average.
- News impactSome1 news items and filings in two weeks; 0 rated high impact, 1 medium.
Signals describe activity, not recommendations. Not financial advice.
Leveraged ETF flows
Estimated leveraged-ETF rebalance on Oct 27: buy ₩388M at the close (2.2% of 20-day average trading value)
On its 33 biggest days of the last 60 (moves of 3%+), the estimated pressure averaged 0.9% of trading value and pointed the same way 22 of 33 times.
- 2× KODEX KOSDAQ150 Leverage ₩316M
- 2× TIGER KOSDAQ150 Leverage ₩38M
- -1× KODEX KOSDAQ150 Futures Inverse ₩22M
- 2× RISE KOSDAQ150 Futures Leverage ₩6.6M
- 2× KIWOOM KOSDAQ150 Futures Leverage ₩1.7M
Mostly via futures: index funds hedge with KOSPI 200 / KOSDAQ 150 futures, spread here over the index's largest members by market value.
Final after the close. An intraday "if the close were now" estimate needs real-time prices, which we don't have yet.
Estimate based on ETF size and daily moves; actual trades may differ.
ETFs holding this
All ETFs →Held by 11 funds.
- KODEX KOSDAQ1500.5%
- KODEX KOSDAQ150 Leverage2×0.5%
- TIGER KOSDAQ1500.5%
- RISE KOSDAQ1500.5%
- TIGER KOSDAQ150 Leverage2×0.5%
- ACE KOSDAQ 1500.5%
- KIWOOM KOSDAQ1500.5%
- SOL KOSDAQ1500.5%
Estimated from the funds' index or underlying stock.
Ingenia Therapeutics stock overview
Ingenia Therapeutics (인제니아테라퓨틱스(Reg.S), KRX: 950260) is listed on KOSDAQ, in the Biotech & Pharma sector. Its shares closed at ₩23,250 on Oct 27, 2026, up 0.22% on the day, giving it a market value of ₩1.1T.
Key facts
- Market cap
- ₩1.1T
- Sector
- Biotech & Pharma
- Latest price change
- +0.22%
- As of
- Oct 27, 2026
Quick answers about Ingenia Therapeutics
- What is the market cap of Ingenia Therapeutics?
- The market capitalisation of Ingenia Therapeutics was ₩1.1T at the close on Oct 27, 2026.
- Who are the largest shareholders of Ingenia Therapeutics?
- According to the latest official filings, the largest reported holders are Han Sang-yeol (74.60%, as of Sep 29, 2026); Aureum Asset Management (19.68%, as of Aug 25, 2026); InterVest Open Innovation Private Equity Investment (12.16%, as of Aug 25, 2026).
- When is the next earnings report from Ingenia Therapeutics?
- Korean companies rarely announce results dates in advance. Based on when Ingenia Therapeutics filed the same report in past years, its next 2q results is expected around Aug 19, 2027.
Company profile
Loading data for this company — check back soon
- Korean name
- 인제니아테라퓨틱스(Reg.S)
- Sector
- Biotech & Pharma
- Themes
- Biotech (new drugs)
- CEO
- 한상열
- Founded
- Mar 2018
- Listed
- Aug 2026
- Listed shares
- 49,444,607
- Fiscal year ends
- Month 12
- Website
- www.ingeniatx.com
Similar companies
- Samsung Biologics207940 · ₩64T₩1,374,000−5.37%
- Celltrion068270 · ₩44T₩188,600−0.74%
- Alteogen196170 · ₩15T₩218,5000.00%
- Yuhan000100 · ₩5.9T₩80,000−2.08%
- SK biopharmaceuticals326030 · ₩5.9T₩74,900−1.19%
- HLB028300 · ₩5.3T₩39,900+1.66%
- Hanmi Pharm128940 · ₩4.5T₩350,500−0.57%
- SAM Chun Dang Pharm000250 · ₩4.4T₩187,600−0.69%
Recent filings
See all- Major management matter relevant to investorsOct 27, 2026
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent DirectorsSep 30, 2026
- 5%+ holding reportSep 29, 2026
- Major management matter relevant to investorsSep 28, 2026
- Major management matter relevant to investorsSep 28, 2026
Titles in Korean until English translations are added.
Also known as: Ingenia Therapeutics / 인제니아테라퓨틱스(Reg.S) / 950260 / KRX:950260
Source: KRX statistical information